Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 2
3(60.0%)
Phase 1
2(40.0%)
5Total
Phase 2(3)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04018612Phase 2Completed

A Study of Acetaminophen for Post Surgical Dental Pain

Role: lead

NCT04495283Phase 2Completed

A Phase 2 Study to Evaluate Pregabalin and Acetaminophen Compared to Acetaminophen and Placebo in Subjects Undergoing Bunionectomy

Role: lead

NCT03652818Phase 2Completed

Dental Pain Study of Analgesics in Patients Undergoing Molar Removal

Role: lead

NCT04883996Phase 1Unknown

A Phase 1/2 Crossover Study to Assess EXP039 for Myopia or Hyperopia

Role: collaborator

NCT04265456Phase 1Completed

A Phase 1 Study to Evaluate Pregabalin and Acetaminophen in Healthy Volunteers

Role: lead

All 5 trials loaded